Clinical Vignettes: Donor-Derived Infections

Patients undergoing solid organ transplantation (SOT) may acquire infections from the transplanted organ. Routine screening for common infections are an established part of the pretransplant evaluation of donors and recipients. Likewise, strategies exist for prophylaxis and surveillance for common donorassociated infections including hepatitis B, CMV and EBV. However, despite advances in diagnostic testing to evaluate the infectious risk of donors, unanticipated transmission of pathogens occurs, particularly when donors are asymptomatic or have subtle or unusual manifestations of a transmissible Infection. Infectious diseases (ID) providers play an integral role in donor and recipient risk assessment and can advise transplant centers on organ utilization and guide evaluation and management of the SOT recipient. Consideration of the donor cause of death and preceding clinical syndromes are important for characterizing the potential risk for recipient infection. This allows a more accurate analysis of the risk: benefit of accepting a life-saving organ and risk of infection. ID providers and transplant teams should work closely with organ procurement organizations (OPOs) to solicit additional donor information when a donor-derived infection is suspected so that reporting can be facilitated to ensure communication with the care-teams of other organ recipients from the same donors. National advisory committees work closely with federal agencies to provide oversight, guide policy development, and assess outcomes to assist with the prevention and management of donor-transmitted disease through organ transplantation. The clinical vignettes in this review highlight some of the complexities in the evaluation of potential donor transmission.

[1]  Organ Procurement and Transplantation Network , 2020, Definitions.

[2]  M. Michaels,et al.  Pediatrics and donor‐derived disease transmission: The US OPTN experience , 2018, Pediatric transplantation.

[3]  E. Elliott,et al.  Influenza-associated Encephalitis/Encephalopathy Identified by the Australian Childhood Encephalitis Study 2013–2015 , 2017, The Pediatric infectious disease journal.

[4]  T. Pruett,et al.  Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes , 2017, Transplantation.

[5]  R. Hasz,et al.  Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients. , 2017, The New England journal of medicine.

[6]  M. Kuehnert,et al.  A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased‐risk organ donors , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[7]  L. Ratner,et al.  A Pilot Program to Evaluate Deceased Donor Disease Transmission Risk: The New York Organ Donor Network Infectious Disease Working Group , 2014, Transplantation.

[8]  D. van Duin,et al.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections. , 2014, World journal of transplantation.

[9]  J. Waggoner,et al.  Rare and Emerging Viral Infections in Transplant Recipients , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Umscheid,et al.  PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Transmission through Organ Transplantation , 2013, Public health reports.

[11]  Michael Green,et al.  Introduction: Infections in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  A. Caliendo,et al.  Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. , 2013, Transplantation.

[13]  L. Kucirka,et al.  Risk of Window Period HIV Infection in High Infectious Risk Donors: Systematic Review and Meta‐Analysis , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  L. Kucirka,et al.  Risk of Window Period Hepatitis‐C Infection in High Infectious Risk Donors: Systematic Review and Meta‐Analysis , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  R. Hasz,et al.  Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  M. Volk,et al.  Centers for Disease Control ‘High‐Risk’ Donors and Kidney Utilization , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  D. Asch,et al.  Transplantation of Kidneys from Donors at Increased Risk for Blood‐Borne Viral Infection: Recipient Outcomes and Patterns of Organ Use , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  R. Hasz,et al.  Donor‐Derived Disease Transmission Events in the United States: Data Reviewed by the OPTN/UNOS Disease Transmission Advisory Committee , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[19]  D. Pegues,et al.  Use of hearts transplanted from donors with severe sepsis and infectious deaths. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  A. Khaghani,et al.  Intrathoracic organ transplantation from donors with meningitis: a single-center 20-year experience. , 2008, The Annals of thoracic surgery.

[21]  F. Hayden,et al.  Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. , 2006, The Journal of infectious diseases.

[22]  J. Aguado,et al.  Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  C. Santiago,et al.  Successful transplantation of organs retrieved from donors with bacterial meningitis. , 1997, Transplantation.